What is prep-aware waitlist backfill for endoscopy?
Prep-aware waitlist backfill recovers a cancelled colonoscopy slot by routing it to a patient who can actually be prep-ready for that date, not just the next person on the list who says yes. It matters because an empty endoscopy room is lost revenue, and generic backfill cannot recover it: the replacement needs 1 to 2 days of bowel preparation, so offering them tomorrow’s freed slot just produces another no-show. Aescia for Clinics tracks prep state across the active list, so when a slot frees up it can find someone genuinely ready to take it.
Generic waitlist auto-fill is table-stakes parity that many tools offer. Prep-aware backfill is the genuine differentiator, and Aescia only claims the version it actually builds. Aescia is pre-first-customer and is not a medical device.
Why prep-blind backfill fails for colonoscopy.
Most waitlist auto-fill tools treat a colonoscopy slot like any other appointment: a slot opens, the tool calls the next person on the list, the slot is “filled.” For a clinic consultation that works. For a colonoscopy it usually does not, because a colonoscopy is not just an appointment, it is an appointment the patient must spend 1 to 2 days preparing for.
A patient pulled off the waitlist into tomorrow’s freed slot has not done the bowel prep. They either decline, or they accept and then cannot attend properly, or they arrive inadequately prepared and the procedure is repeated. The slot looks filled in the scheduling system and is effectively lost in the room. Prep-blind backfill moves the problem; it does not solve it.
Most tools ask who wants the slot. Aescia asks who can be ready for it.
When a colonoscopy slot frees up, the question that matters is not who will say yes fastest. It is who can complete bowel prep, medication holds, and fasting in the time left. Here is the loop, end to end:
- 01Patients confirm attendance at each prep check-inEvery patient on a prep pathway is asked to confirm they are still attending at each check-in along the way.
- 02A wavering or missed confirmation is the early signalWhen a patient stops confirming, or signals they may not make it, that is often the first sign a slot may free up, ahead of a cancellation call reaching the front desk.
- 03Aescia finds a candidate who can actually be readyIt looks for a patient already prep-ready, or far enough along to be ready in time for that date, rather than calling down the list blind.
- 04Aescia keeps that candidate’s prep on trackThe candidate is kept moving through prep so they are genuinely ready to take the slot, not just willing to.
- 05Staff hear about the change in the morningAescia surfaces the recovered slot and who is covering it to staff in the morning, as a clear hand-off, not a midnight scramble.
- 06The clinic books it in its own schedulerStaff confirm and book the recovered slot in your scheduling system. Aescia produces the signal and the prepped candidate; it does not write to your scheduler.
To be precise about what this is and is not: Aescia does not predict cancellations with a model, and it does not book or write to your scheduler. It reads the attendance signals patients already give at check-in, finds and preps a suitable candidate, and hands the change to your staff. Recovery rests on the prep pathway existing first, see how the prep pathway works.
The clinic decides who is eligible, in a setup wizard.
You set the rules once in a short setup wizard, choosing exactly which short-notice swaps you are comfortable with: how late is too late to move a patient up, which medication situations are eligible, and what transport and clearance you require. Aescia only offers a freed slot to a candidate who clears your rules.
In practice a candidate qualifies only if they can realistically be ready: enough prep time left, bowel prep on track, medication holds handled (GLP-1, anticoagulant, and diabetic), fasting and transport sorted, and pre-procedure clearance done.
| Generic waitlist tool | Aescia |
|---|---|
| Fills any appointment opening | Recovers prep-dependent endoscopy slots |
| Offers it to the first patient who says yes | Offers it to a patient who can actually be ready in time |
| No prep context | Prep state, medication holds, fasting, transport, timing |
| Can create rushed, poorly-prepped cases | Filters out candidates who cannot prep in time |
What one recovered slot a week adds up to.
One recovered colonoscopy slot a week is about 50 a year. At an ambulatory surgery center facility fee of roughly US$989 to US$1,034 per slot (Allen 2023), that is about US$50,000 a year in recovered facility revenue, before professional and pathology fees.
That figure is the published facility-fee number applied to a recovered slot, not a result Aescia has measured at a customer. Aescia is pre-first-customer. Put your own scope volume, cancellation rate, and facility fee into the ROI calculator on the Clinics page to see your own range.
It can only pull from the prepping pool.
Recovery only works when someone is genuinely ready. Aescia pulls from the patients already prepping, so the ceiling is set by how full that pool is. If only a handful of patients are in the prep window when a slot opens, the recovery rate is low, because there is no one ready to take it. The mechanism does not manufacture prepped patients; it makes use of the ones who already are.
So prep-aware recovery is most valuable for ASCs with enough near-term volume to keep a meaningful prepping pool, and least valuable for very low-volume lists. It is a routing signal and a prepped candidate, not a guarantee that every freed slot is recovered. Aescia states this plainly because over-claiming here is exactly what erodes trust with a buyer who runs the list every day.
Where competitors are genuinely stronger, and where Aescia fits, is laid out in the comparison and the fit page.
- Product
- Aescia for Clinics
- Category
- Pre-procedure patient-pathway software for endoscopy ambulatory surgery centers (ASCs).
- Founded
- 2025.
- Headquarters
- Sydney, Australia and Montréal, Canada.
- Regulatory status
- Aescia for Clinics is not a medical device. Its sibling product, Aescia for Hospitals, is an investigational software as a medical device, intended for Class IIa classification under the Australian TGA. No device application has been lodged for either product.
- Clinical evidence
- SAFE-Discharge trial (ACTRN12625001425482) at Royal Prince Alfred Hospital, Sydney, evaluating the Hospitals product across the 30-day post-discharge window.
- Integration targets
- Designed to work alongside common endoscopy systems including Provation, EndoWorks, and gGastro. No integration is live yet; Aescia is pre-first-customer, and any data exchange is scoped per customer.
- Pricing
- United States: US$8 per scope at the institutional tier; US$6 per scope for multi-state aggregators above 50,000 scopes per year. No per-seat pricing.
- Deployment stage
- Pre-first-customer. Clinics customers engage through the design-partner program, which runs free or under a money-back rebate until Aescia delivers measurable net benefit against the ASC’s own baseline.
If freed colonoscopy slots are going unfilled because the replacements are not prepped, the design-partner pilot runs free or under a money-back rebate until Aescia delivers measurable net benefit against your own baseline.